LAWSUITS NEWS & LEGAL INFORMATION
DaVita Dialysis Centers Settle Lawsuit for $55 Million
This is a settlement for the Medical Malpractice lawsuit.
New York, NY: A $55 million settlement has been reached in a medical malpractice lawsuit alleging dialysis service provider DaVita Inc. overused an anemia medication.
The lawsuit, filed in 2002, is based on a whistleblower's claim that DaVita overused Epogen, an anemia drug made by Amgen, over a 10-year period. Epogen is used to increase red blood cell counts and thereby reduce anemia and the need for blood transfusions.
DaVita says its physicians did nothing wrong and stand by their anemia management practices, but the company says the agreement is in the best interest of its shareholders. Davita is based in Denver an operates approximately 1,800 outpatient dialysis centers across the US.
Published on Jul-4-12
The lawsuit, filed in 2002, is based on a whistleblower's claim that DaVita overused Epogen, an anemia drug made by Amgen, over a 10-year period. Epogen is used to increase red blood cell counts and thereby reduce anemia and the need for blood transfusions.
DaVita says its physicians did nothing wrong and stand by their anemia management practices, but the company says the agreement is in the best interest of its shareholders. Davita is based in Denver an operates approximately 1,800 outpatient dialysis centers across the US.
Legal Help
If you have a similar problem and would like to be contacted by a lawyer at no cost or obligation, please click the link below.Published on Jul-4-12
